We’re excited to introduce and welcome Joanna Sax as a guest blogger for the month of May.
Joanna is an Associate Professor of Law at California Western School of Law. She teaches Contracts, Trusts & Estates and a seminar entitled Law, Science & Medicine. Her main area of research is biomedical policy; specifically, how to create incentives to advance scientific research and protect scientific integrity. In this area, Joanna has recently focused on issues such as financial conflicts of interest and the relationship of politics and science. Another area of interest is FDA regulation; Joanna will be presenting at the upcoming conference on the FDA in the 21st Century hosted by Petrie-Flom. Prior to focusing her research interests on the intersection of law and science, she was a molecular biologist and spent years researching cancer.
Joanna attended the University of Wisconsin – Madison, where she earned a B.S. After undergraduate school, she was a pre-doctoral fellow at the National Cancer Institute. In 1999, following her fellowship, she began a PhD program in Cell and Molecular Biology at the University of Pennsylvania School of Medicine. In 2003, after earning a PhD, she entered law school at the University of Pennsylvania. After law school, she spent 2 and a half years as an attorney at Morgan, Lewis & Bockius, LLP. In 2009, Joanna joined the faculty at California Western School of Law.
Some of Joanna’s recent publications include:
- Application of Default Rules to Address Financial Conflicts of Interest in Academic Medical Centers, 87 Ind. L. J. Supp. 53 (2012). http://papers.ssrn.com/sol3/papers.cfm?abstract_id=2040869
- Financial Conflicts of Interest in Science, 21 Loy. Annals Health L. 291 (2012). http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1898385
- Evaluation of Academic Scientists’ Responses to Situations that Pose a Conflict of Interest, 12 Cancer Biology & Therapy 4 (2011) (with Neal Doran). http://www.landesbioscience.com/journals/cbt/article/15718/
- Protecting Scientific Integrity: The Commercial Speech Doctrine Applied to Industry Publications, 37 Am. J. L. & Med. 203 (2011) (symposium). http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1885786
- Access to Prescription Drugs: A Normative Economic Approach to Pharmacist Conscience Clause Legislation, 63 Maine L. Rev. 89 (2010). http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1423562
- Reforming FDA Policy for Pediatric Testing: Challenges and Changes in the Wake of Studies Using Anti-Depressant Drugs, 4 Ind. Health L. Rev. 62 (2007). http://indylaw.indiana.edu/ihlr/authors.cfm?ltr=S
- The States “Race” with the Federal Government for Stem-Cell Research, 15 Loy. Annals Health L. 1 (2006). http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1425715